Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Strom

Showing results (221-230 of 283) with videos related to

Pageof 29
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001
Impact of systemic treatment on local control for patients with lymph node-negative breast cancer treated with breast-conservation therapyT A Buchholz, S L Tucker, J Erwin, et al.
Annals of Surgical Oncology|August 24, 2011
Evaluation of the MD Anderson Prognostic Index for local-regional recurrence after breast conserving therapy in patients receiving neoadjuvant chemotherapyCatherine L Akay, Funda Meric-Bernstam, Kelly K Hunt, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 2008
Risk of subclinical micrometastatic disease in the supraclavicular nodal bed according to the anatomic distribution in patients with advanced breast cancerValerie K Reed, Jose L Cavalcanti, Eric A Strom, et al.
Springerplus|February 13, 2015
The 21-gene recurrence score complements IBTR! Estimates in early-stage, hormone receptor-positive, HER2-normal, lymph node-negative breast cancerNikhil G Thaker, Karen E Hoffman, Michael C Stauder, et al.
Cancer|November 2, 2002
Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrencesEugene Huang, Thomas A Buchholz, Funda Meric, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2006
Locoregional control of clinically diagnosed multifocal or multicentric breast cancer after neoadjuvant chemotherapy and locoregional therapyJulia L Oh, Mark J Dryden, Wendy A Woodward, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 13, 2006
Multileaf field-in-field forward-planned intensity-modulated dose compensation for whole-breast irradiation is associated with reduced contralateral breast dose: a phantom model comparisonYerko O Borghero, Mohammad Salehpour, Marsha D McNeese, et al.
Journal of the National Cancer Institute|November 18, 2004
Clinically relevant pneumonitis after sequential paclitaxel-based chemotherapy and radiotherapy in breast cancer patientsTse-Kuan Yu, Gary J Whitman, Howard D Thames, et al.
Hypertension (Dallas, Tex. : 1979)|November 17, 2001
One-year study of felodipine or placebo for stage 1 isolated systolic hypertensionH R Black, W J Elliott, M A Weber, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 2008
Radiation use and long-term survival in breast cancer patients with T1, T2 primary tumors and one to three positive axillary lymph nodesThomas A Buchholz, Wendy A Woodward, Zhigang Duan, et al.
Pageof 29

Showing results (221-230 of 283) with videos related to

Sort By:
Pageof 29
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001
Impact of systemic treatment on local control for patients with lymph node-negative breast cancer treated with breast-conservation therapyT A Buchholz, S L Tucker, J Erwin, et al.
Annals of Surgical Oncology|August 24, 2011
Evaluation of the MD Anderson Prognostic Index for local-regional recurrence after breast conserving therapy in patients receiving neoadjuvant chemotherapyCatherine L Akay, Funda Meric-Bernstam, Kelly K Hunt, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 2008
Risk of subclinical micrometastatic disease in the supraclavicular nodal bed according to the anatomic distribution in patients with advanced breast cancerValerie K Reed, Jose L Cavalcanti, Eric A Strom, et al.
Springerplus|February 13, 2015
The 21-gene recurrence score complements IBTR! Estimates in early-stage, hormone receptor-positive, HER2-normal, lymph node-negative breast cancerNikhil G Thaker, Karen E Hoffman, Michael C Stauder, et al.
Cancer|November 2, 2002
Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrencesEugene Huang, Thomas A Buchholz, Funda Meric, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2006
Locoregional control of clinically diagnosed multifocal or multicentric breast cancer after neoadjuvant chemotherapy and locoregional therapyJulia L Oh, Mark J Dryden, Wendy A Woodward, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 13, 2006
Multileaf field-in-field forward-planned intensity-modulated dose compensation for whole-breast irradiation is associated with reduced contralateral breast dose: a phantom model comparisonYerko O Borghero, Mohammad Salehpour, Marsha D McNeese, et al.
Journal of the National Cancer Institute|November 18, 2004
Clinically relevant pneumonitis after sequential paclitaxel-based chemotherapy and radiotherapy in breast cancer patientsTse-Kuan Yu, Gary J Whitman, Howard D Thames, et al.
Hypertension (Dallas, Tex. : 1979)|November 17, 2001
One-year study of felodipine or placebo for stage 1 isolated systolic hypertensionH R Black, W J Elliott, M A Weber, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 2008
Radiation use and long-term survival in breast cancer patients with T1, T2 primary tumors and one to three positive axillary lymph nodesThomas A Buchholz, Wendy A Woodward, Zhigang Duan, et al.
Pageof 29